BTK-IN-5

• UNSPSC Description:

  BTK-IN-5 is a covalent BTK inhibitor for researching medical conditions such as cardiovascular diseases, respiratory diseases, inflammation, and diabetes.

• Target Antigen:

  Btk

• Type:

  Reference compound

• Related Pathways:

  Protein Tyrosine Kinase/RTK

• Applications:

  Metabolism-protein/nucleotide metabolism

• Field of Research:

  Metabolic Disease; Inflammation/Immunology; Cardiovascular Disease

• Assay Protocol:

  https://www.medchemexpress.com/btk-in-5.html

• Solubility:

  10 mM in DMSO

• Smiles:

  CNC([C@H](NC([C@H]([C@H](OC(C)(C)C)C)NC([C@@]1(CO1)C)=O)=O)CC2=CC=C(C=C2)C#N)=O

• Molecular Weight:

  444.52

• References & Citations:

  [1]Clark M, et al. Covalent btk inhibitors and uses thereof. WO2017190048A1.

• Shipping Conditions:

  Room temperature

• Clinical Information:

  No Development Reported

• CAS Number:

  2145152-06-1